(Q51500912)

6 April 2018

title

Peptide YY levels are elevated after gastric bypass surgery. (English)

1 reference

6 April 2018

author

Allison B Goldfine

5

1 reference

6 April 2018

Christos Socrates Mantzoros

4

object named as

Christos S Mantzoros

1 reference

6 April 2018

author name string

Jean L Chan

1

1 reference

6 April 2018

Edward C Mun

2

1 reference

6 April 2018

Violeta Stoyneva

3

1 reference

6 April 2018

publication date

1 February 2006

1 reference

6 April 2018

published in

Obesity

1 reference

6 April 2018

volume

14

1 reference

6 April 2018

issue

2

1 reference

6 April 2018

page(s)

194-198

1 reference

6 April 2018

Human distribution and release of a putative new gut hormone, peptide YY

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.25

Does gut hormone PYY3–36 decrease food intake in rodents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.25

Current status of medical and surgical therapy for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.25

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.25

Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.25

Gut hormone PYY(3-36) physiologically inhibits food intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.25

Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.25

Inhibition of food intake in obese subjects by peptide YY3-36

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.25

Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.25

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.25

Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.25

Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.25

Characterization of cholecystokininA and cholecystokininB receptors expressed by vagal afferent neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.25

Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.25

Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.25

Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.25

31 March 2020

Identifiers

DOI

10.1038/OBY.2006.25

1 reference

6 April 2018

PubMed ID

16571843

1 reference

6 April 2018